TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

HUB

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

HUB

ST13

US500000079258264

Classe

1, 5, 42, 44

Pedido

79258264

Registro

6050134

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

53

Atualização mais recente

02/11/2025

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

1, 5, 42, 44

Data de depósito

29/11/2018

Data de registro

12/05/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

12/05/2020

Última transação

02/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

78

Localização do titular

NL

Examinador

MOLINOFF,JEFFREY S.

Unidade examinadora

N40

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consist of the teal stylized wording "HUB" and a stylized outline design of cells in shades of teal. The white inside the cells is background only and is not claimed as a feature of the mark.

Titulares e representantes

Titulares

HUB Organoids IP B.V.
HUB Organoids B.V. IP
S. T. (pessoa física)

Representantes

William C. Wright Epstein Drangel LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Cells, stem cells, epithelial cells, all for scientific research purposes; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures, for scientific and research use; cell culture reagents for scientific and research use; cell culture media for scientific and research use; diagnostic preparations and reagents for use in science; chemicals used in science and industry; assays and assay reagents for scientific purposes; cell culture media for scientific research purposes

Classe 5

Cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; stem cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; epithelial cells for medical and veterinary diagnostic and therapeutic purposes, namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures for medical and veterinary diagnostic and therapeutic purposes namely for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cell cultures for medical and veterinary diagnostic and therapeutic purposes, namely, cells grown in culture media for use in diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; diagnostic and analytical preparations for medical purposes; biological tissue cultures for medical and veterinary purposes; assays and assay preparations for medical and veterinary diagnostic testing of cells, cultures and organoids for therapeutic purposes; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; pharmaceutical and veterinary preparations for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases or disorders of epithelial tissue in the sensory, reproductive, urinary, digestive, circulatory, endocrine, nervous, lymphatic, integumentary, or respiratory systems; cells, epithelial cells, organoids and cell cultures for personalised medicine, namely, for diagnosis and treatment of diseases of epithelial tissue in the liver, pancreas, intestine, stomach, prostate, lung, breast, kidney, ovarian, uterus, fallopian tube, sweat gland, hair follicle, skin, oesophagus, thyroid, nose, throat, sinus, trachea, oral cavity, salivary gland, larynx or pharynx

Classe 42

Scientific research; genetic testing for scientific research purposes; medical and pharmacological research services; pharmaceutical drug and vaccine development services; development of pharmaceutical preparations and medicines; medical compound, drug and vaccine discovery, development services, and characterization and validation services in the nature of product quality and efficacy testing for medical compounds, drugs and vaccines; candidate drug and vaccine, drug and vaccine testing services, namely, testing of pharmaceuticals; companion diagnostics, namely, the scientific testing and evaluation of drugs and vaccines for individuals or groups of patients to determine the safety and effectiveness of the drug or vaccine for those patients; food safety testing services; testing of compounds and substances to determine toxicity to cells and organoids, namely, self-organized three-dimensional tissue cultures derived from stem cells and cell cultures; scientific research and diagnostic services in the field of personalized medicine

Classe 44

Medical services and surgery; medical and surgical diagnostic services; medical services in the nature of cell transplantation services

Publicações

Histórico de despachos e eventos da marca no USPTO.

53 publicações encontradas

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

28/10/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

28/10/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

28/10/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

28/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

28/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

28/10/2025

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

12/05/2025

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

07/05/2024

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/04/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/10/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

15/09/2020

FIMP

FINAL DISPOSITION PROCESSED

15/09/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/08/2020

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/02/2020

PUBO

PUBLISHED FOR OPPOSITION

25/02/2020

GPNX

NOTIFICATION PROCESSED BY IB

22/02/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/02/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/02/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/02/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

22/01/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

22/01/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

22/01/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

22/01/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

22/01/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

21/01/2020

GPNX

NOTIFICATION PROCESSED BY IB

17/01/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

14/01/2020

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

06/01/2020

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/01/2020

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/01/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2020

ALIE

ASSIGNED TO LIE

19/12/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

17/12/2019

XAEC

EXAMINER'S AMENDMENT ENTERED

17/12/2019

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

17/12/2019

GNEA

EXAMINERS AMENDMENT E-MAILED

17/12/2019

CNEA

EXAMINERS AMENDMENT -WRITTEN

17/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/12/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/12/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/08/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/07/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/07/2019

RFNT

REFUSAL PROCESSED BY IB

28/06/2019

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/06/2019

RFRR

REFUSAL PROCESSED BY MPU

10/06/2019

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

29/05/2019

CNRT

NON-FINAL ACTION WRITTEN

28/05/2019

MAFR

APPLICATION FILING RECEIPT MAILED

14/05/2019

DOCK

ASSIGNED TO EXAMINER

10/05/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/05/2019

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/05/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace HUB ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.